These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 25341435

  • 1. Rituximab for the treatment of IgG4-related orbital disease: experience from five cases.
    Wu A, Andrew NH, Tsirbas A, Tan P, Gajdatsy A, Selva D.
    Eye (Lond); 2015 Jan; 29(1):122-8. PubMed ID: 25341435
    [Abstract] [Full Text] [Related]

  • 2. IgG4-related systemic disease as a cause of "idiopathic" orbital inflammation, including orbital myositis, and trigeminal nerve involvement.
    Wallace ZS, Khosroshahi A, Jakobiec FA, Deshpande V, Hatton MP, Ritter J, Ferry JA, Stone JH.
    Surv Ophthalmol; 2012 Jan; 57(1):26-33. PubMed ID: 22018678
    [Abstract] [Full Text] [Related]

  • 3. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review.
    Wallace ZS, Deshpande V, Stone JH.
    Semin Arthritis Rheum; 2014 Jun; 43(6):806-17. PubMed ID: 24513111
    [Abstract] [Full Text] [Related]

  • 4. Successful "medical" orbital decompression with adjunctive rituximab for severe visual loss in IgG4-related orbital inflammatory disease with orbital myositis.
    Chen TS, Figueira E, Lau OC, McKelvie PA, Smee RI, Dawes LC, Agar A, Wilcsek G, Francis IC.
    Ophthalmic Plast Reconstr Surg; 2014 Jun; 30(5):e122-5. PubMed ID: 24481505
    [Abstract] [Full Text] [Related]

  • 5. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease.
    Khosroshahi A, Bloch DB, Deshpande V, Stone JH.
    Arthritis Rheum; 2010 Jun; 62(6):1755-62. PubMed ID: 20191576
    [Abstract] [Full Text] [Related]

  • 6. Rituximab for the Treatment of IgG4-Related Tubulointerstitial Nephritis: Case Report and Review of the Literature.
    McMahon BA, Novick T, Scheel PJ, Bagnasco S, Atta MG.
    Medicine (Baltimore); 2015 Aug; 94(32):e1366. PubMed ID: 26266393
    [Abstract] [Full Text] [Related]

  • 7. Bilateral Orbital IgG4-Related Disease with Systemic and Corneal Involvement Showing an Excellent Response to Steroid and Rituximab Therapy: Report of a Case with 11 Years Follow-Up.
    Berta AI, Agaimy A, Braun JM, Manger B, Kruse FE, Holbach L.
    Orbit; 2015 Aug; 34(5):299-301. PubMed ID: 26362833
    [Abstract] [Full Text] [Related]

  • 8. The impact of IgG-4-ROD on the diagnosis of orbital tumors: A retrospective analysis.
    Andron A, Hostovsky A, Nair AG, Sagiv O, Schiby G, Simon GB.
    Orbit; 2017 Dec; 36(6):359-364. PubMed ID: 28829660
    [Abstract] [Full Text] [Related]

  • 9. Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4-related Disease.
    Majumder S, Mohapatra S, Lennon RJ, Piovezani Ramos G, Postier N, Gleeson FC, Levy MJ, Pearson RK, Petersen BT, Vege SS, Chari ST, Topazian MD, Witzig TE.
    Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1947-1953. PubMed ID: 29526692
    [Abstract] [Full Text] [Related]

  • 10. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients.
    Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH.
    Medicine (Baltimore); 2012 Jan; 91(1):57-66. PubMed ID: 22210556
    [Abstract] [Full Text] [Related]

  • 11. An analysis of IgG4-related disease (IgG4-RD) among idiopathic orbital inflammations and benign lymphoid hyperplasias using two consensus-based diagnostic criteria for IgG4-RD.
    Andrew NH, Sladden N, Kearney DJ, Selva D.
    Br J Ophthalmol; 2015 Mar; 99(3):376-81. PubMed ID: 25185258
    [Abstract] [Full Text] [Related]

  • 12. Sustained clinical response after single course of rituximab as first-line monotherapy in adult-onset asthma and periocular xanthogranulomas syndrome associated with IgG4-related disease: A case report.
    Pomponio G, Olivari D, Mattioli M, Angeletti A, Rossetti G, Goteri G, Gabrielli A.
    Medicine (Baltimore); 2018 Jun; 97(26):e11143. PubMed ID: 29952960
    [Abstract] [Full Text] [Related]

  • 13. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
    Ooka S, Maeda A, Ito H, Omata M, Yamada H, Ozaki S.
    Mod Rheumatol; 2009 Jun; 19(1):80-3. PubMed ID: 18806927
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience.
    Hart PA, Topazian MD, Witzig TE, Clain JE, Gleeson FC, Klebig RR, Levy MJ, Pearson RK, Petersen BT, Smyrk TC, Sugumar A, Takahashi N, Vege SS, Chari ST.
    Gut; 2013 Nov; 62(11):1607-15. PubMed ID: 22936672
    [Abstract] [Full Text] [Related]

  • 16. High prevalence of IgG4-related lymphoplasmacytic infiltrative disorder in 25 patients with orbital inflammation: a retrospective case series.
    Deschamps R, Deschamps L, Depaz R, Coffin-Pichonnet S, Belange G, Jacomet PV, Vignal C, Benillouche P, Herdan ML, Putterman M, Couvelard A, Gout O, Galatoire O.
    Br J Ophthalmol; 2013 Aug; 97(8):999-1004. PubMed ID: 23759440
    [Abstract] [Full Text] [Related]

  • 17. IgG4-related disease with cutaneous manifestations treated with rituximab: case report and literature review.
    Jalilian C, Prince HM, McCormack C, Lade S, Cheah CY.
    Australas J Dermatol; 2014 May; 55(2):132-6. PubMed ID: 24032760
    [Abstract] [Full Text] [Related]

  • 18. IgG4-Related Ophthalmic Disease. Part II: Clinical Aspects.
    McNab AA, McKelvie P.
    Ophthalmic Plast Reconstr Surg; 2015 May; 31(3):167-78. PubMed ID: 25564258
    [Abstract] [Full Text] [Related]

  • 19. IgG4-related disease in the eye and ocular adnexa.
    Derzko-Dzulynsky L.
    Curr Opin Ophthalmol; 2017 Nov; 28(6):617-622. PubMed ID: 28858963
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.